FDA Changes Fluoroquinolone Label But Denies Citizen Petition on Mitochondrial Toxicity

On Thursday May 12, 2016 the FDA contacted those who have been pursuing label changes for the Fluoroquinolones and issued a public statement that the FDA is requiring label changes for antibacterial drugs called fluoroquinolones

By |2016-05-12T19:17:11-05:00May 12th, 2016|Advocacy, FDA, FQ Community News|4 Comments

Dr. Bennett Publishes Paper on Fluoroquinolone Neuropsychiatric & Mitochondrial Toxicity

Dr. Charles Bennett has been able to successfully publish a paper titled "Fluoroquinolone-Related Neuropsychiatric and Mitochondrial Toxicity: a collaborative investigation by scientists and members of a social network."

By |2016-02-04T13:50:56-05:00February 4th, 2016|Research|2 Comments

Becoming a Danger to One’s Self and/or Others by Taking a Fluoroquinolone

It is very disturbing that an antibiotic, which is often given out for routine infections, may result in violence, anger toward others, and horribly, may result in suicide-related adverse events.

By |2015-11-24T20:02:00-05:00November 24th, 2015|FDA, Psychological|1 Comment

The Voices Heard Round The World – The November 5th FDA Meeting

On Nov. 5th, the true stars of our community took to the podium at the FDA to tell their personal stories. I, along with countless others, were humbled and honored. This meeting represented a huge step in the progress we are making to gain complete recognition of the travesty that the fluoroquinolone class of pharmaceuticals has wrought upon society, to achieve justice for those that have been damaged by these drugs, and to prevent future unnecessary pain and suffering not only for this generation, but for generations to come.

By |2015-11-10T19:55:39-05:00November 10th, 2015|Advocacy, FQ Community News|9 Comments

Fluoroquinolone Academic Research Update – Dr. Mark Noble, Part #1

A interesting two part series covering our five year research relationship with Dr. Noble, U of R; He has assisted us with a submission for the upcoming FDA Meeting, asked us to collect data for his research, and in part 2 reveals troubling findings about Levaquin.

By |2015-10-25T19:02:57-05:00October 24th, 2015|Research|3 Comments

FDA To Hold Upcoming Meeting on Fluoroquinolones

We believe that the attention given the Fluoroquinolones through the combined media stories, past rallies, citizen petitions, in addition to community members meeting directly with FDA officials, provided some of the impetus, in part, for the scrutiny of the Fluoroquinolones being prescribed for these common health conditions.

By |2015-10-02T17:36:39-05:00October 2nd, 2015|Advocacy, FQ Community News|2 Comments

Fluoroquinolone Community Goes to the FDA: Pediatrics and Rhabdomyolysis

On August 24th, 2015, members from the FQ community met with staff from the FDA in a third meeting to address the various FDA failures to adequately warn the general public about the true dangers FQ's pose to the general public, especially our children.

By |2015-08-30T11:06:50-05:00August 30th, 2015|Advocacy, FDA, FQ Community News|0 Comments

New Dear Colleague Letter

Dr. Miriam J. de Jonge M.D., who herself was floxed has contacted me and asked me to post, what I feel, is a comprehensive and well documented "Dear Colleague" letter, informing other doctors of (FQ) toxicity. It can be used to foster patient/doctor discussions. It is available here to download.

By |2015-08-08T12:50:39-05:00August 8th, 2015|Advocacy, Doctors, FQ Community News, General Medical|2 Comments

T-Shirt Fundraiser For Fluoroquinolone Awareness

Please help support our fundraising t-shirt campaign, which will provide visual awareness to the eyes of the world, and assist us with operating costs. We have designed a t-shirt to help bring FQ awareness to the general public, but this cannot happen without your assistance.

By |2015-07-02T11:44:42-05:00July 2nd, 2015|Advocacy|1 Comment
Go to Top